12:00 AM
Feb 27, 2012
 |  BC Week In Review  |  Company News  |  Deals

Xencor, Boehringer Ingelheim deal

Boehringer will provide all manufacturing and product supply for undisclosed Xencor mAbs from preclinical through Phase I testing....

Read the full 69 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >